David Peacock Left a $10 Billion Vaccine Business for a Patch You Can Barely See

After more than two decades at Merck, David Peacock chose a Brisbane biotech, a square of microscopic projections and one large question: can vaccination become easier to ship, simpler to give and practical to use at home?